DE69941099D1 - Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria - Google Patents

Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria

Info

Publication number
DE69941099D1
DE69941099D1 DE69941099T DE69941099T DE69941099D1 DE 69941099 D1 DE69941099 D1 DE 69941099D1 DE 69941099 T DE69941099 T DE 69941099T DE 69941099 T DE69941099 T DE 69941099T DE 69941099 D1 DE69941099 D1 DE 69941099D1
Authority
DE
Germany
Prior art keywords
neisseria
pathogenic strains
polypeptides
nucleic acids
specific nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69941099T
Other languages
English (en)
Inventor
Luc Aujame
Annabelle Bouchardon
Genevieve Renauld-Mongenie
Bachra Rokbi
Xavier Nassif
Colin Tinsley
Agnes Perrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Sanofi Pasteur Inc
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Sanofi Pasteur Inc filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE69941099D1 publication Critical patent/DE69941099D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69941099T 1998-10-30 1999-10-28 Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria Expired - Lifetime DE69941099D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9813693A FR2785293B1 (fr) 1998-10-30 1998-10-30 Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria

Publications (1)

Publication Number Publication Date
DE69941099D1 true DE69941099D1 (de) 2009-08-20

Family

ID=9532223

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69941099T Expired - Lifetime DE69941099D1 (de) 1998-10-30 1999-10-28 Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria

Country Status (8)

Country Link
US (4) US6835384B1 (de)
EP (4) EP1475441B1 (de)
AT (1) ATE435915T1 (de)
AU (1) AU775986B2 (de)
CA (1) CA2349495A1 (de)
DE (1) DE69941099D1 (de)
FR (1) FR2785293B1 (de)
WO (1) WO2000026375A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
AU1580300A (en) 1998-12-08 2000-06-26 Smithkline Beecham Biologicals (Sa) Novel compounds
GB9902070D0 (en) * 1999-01-29 1999-03-24 Smithkline Beecham Biolog Novel compounds
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
WO2012059593A1 (en) * 2010-11-05 2012-05-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccines for preventing meningococcal infections
AU2013295242C1 (en) 2012-07-27 2018-08-09 Institut National De La Sante Et De La Recherche Medicale CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
WO2017137085A1 (en) 2016-02-11 2017-08-17 Sanofi Pasteur Meningitidis vaccines comprising subtilinases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952496A (en) 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5028530A (en) 1985-01-28 1991-07-02 Xoma Corporation AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
US5015580A (en) 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5147800A (en) * 1990-06-08 1992-09-15 Life Technologies, Inc. Host expressing ngoaiii restriction endonuclease and modification methylase from neisseria
FI903414A (fi) * 1990-07-06 1992-01-07 Kansanterveyslaitos Produktion av proteiner i grampositiva bakterier.
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
CA2131620A1 (en) 1992-03-20 1993-09-30 Louis C. Smith A dna transporter system and method of use
ES2221920T3 (es) 1992-04-03 2005-01-16 The Regents Of The University Of California Sistema de liberacion de polinucleotidos de autoensamblaje que comprende un peptido cationico anfipatico.
ATE302854T1 (de) 1993-01-26 2005-09-15 Univ Pennsylvania Zusammensetzungen und verfahren zur verabreichung von genetischem material
TW360548B (en) 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
SG54115A1 (en) 1993-04-27 1998-11-16 Gerber Scient Products Inc Thermal printing apparatus with improved power supply
DE69433519T2 (de) 1993-07-14 2004-11-11 The Regents Of The University Of California, Oakland Sich selbst zusammensetzendes polynukleotid-abgabesystem, das dendrimer-polykationen enthält
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
EP0839909A1 (de) * 1996-10-29 1998-05-06 Rijksuniversiteit te Groningen Nukleinsäuresequenzen die für Citrat-Transporterproteine Kodieren
US5912143A (en) * 1996-12-27 1999-06-15 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a human mage protein homolog

Also Published As

Publication number Publication date
US20050032103A1 (en) 2005-02-10
US7384768B2 (en) 2008-06-10
US20100184639A1 (en) 2010-07-22
WO2000026375A3 (fr) 2000-08-17
EP1475441A2 (de) 2004-11-10
WO2000026375A2 (fr) 2000-05-11
US7704513B2 (en) 2010-04-27
EP1724352A2 (de) 2006-11-22
US20090155886A1 (en) 2009-06-18
EP1129195A2 (de) 2001-09-05
FR2785293B1 (fr) 2002-07-05
EP2100960A2 (de) 2009-09-16
US6835384B1 (en) 2004-12-28
FR2785293A1 (fr) 2000-05-05
US8309100B2 (en) 2012-11-13
AU775986B2 (en) 2004-08-19
EP2100960A3 (de) 2009-12-02
EP1724352A3 (de) 2007-07-11
EP1475441B1 (de) 2009-07-08
EP1475441A3 (de) 2005-05-04
CA2349495A1 (en) 2000-05-11
AU6347999A (en) 2000-05-22
ATE435915T1 (de) 2009-07-15

Similar Documents

Publication Publication Date Title
Sojar et al. Porphyromonas gingivalis fimbriae bind to cytokeratin of epithelial cells
ATE312920T1 (de) Dna immunisierung gegen chlamydia infektion
Marvaud et al. TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to BotR
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
WO2001073059A3 (en) 38692 and 21117: dual specificity phosphatase molecules and uses therefor
BR0015137A (pt) Peptìdeos antigênicos de neisseria
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
ATE184052T1 (de) Gdf-1 und uog1 proteine
ES2127829T3 (es) Expresion de proteinas recombinantes fusionadas en bacterias atenuadas.
Chung et al. Identification of a Porphyromonas gingivalis receptor for the Streptococcus gordonii SspB protein
NO20011381L (no) Preparater av streptokokk C<beta>-protein
Radulovic et al. Identification and molecular analysis of the gene encoding Rickettsia typhi hemolysin
Xie et al. Regulation of the Porphyromonas gingivalis fimA (fimbrillin) gene
DE69941099D1 (de) Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
ATE480620T1 (de) Neue pgc-1-isoformen und deren verwendungen
Kataoka et al. Secretion of functional salivary peptide by Streptococcus gordonii which inhibits fimbria-mediated adhesion of Porphyromonas gingivalis
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
Kamachi et al. Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
FI963016A0 (fi) Heterologisten proteiinien ilmentäminen heikennetyissä bakteereissa käyttämällä htrA-promoottoreita
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
KLEPPE Characterization of the h1 protein antigen from Staphylococcus aureus 17A
Lammler et al. Relation Between Encapsulation of Streptococci of Serological Group B and Adherence Properties of The Bacteria to Deae-Sephacel
DE50113411D1 (de) Neue humane Androgenrezeptor-Varianten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition